Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Untch

Showing results (111-120 of 377) with videos related to

Pageof 38
Sort By:
Breast Care (Basel, Switzerland)|April 7, 2016
ABC3 Consensus: Assessment by a German Group of ExpertsChristoph Thomssen, Doris Augustin, Johannes Ettl, et al.
Breast Cancer Research and Treatment|December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experienceOtto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.
Cancers|August 25, 2019
Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto TrialMalgorzata Banys-Paluchowski, Sibylle Loibl, Isabell Witzel, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
Discussion of ABC7 Consensus and German RecommendationsMichael Untch, Nina Ditsch, Peter A Fasching, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trialMarcus Schmidt, Ulrike Nitz, Toralf Reimer, et al.
Breast (Edinburgh, Scotland)|February 29, 2024
Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapyDavid Krug, Valentina Vladimirova, Michael Untch, et al.
Journal of the National Cancer Institute|March 4, 2014
ResponseVolker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Oncotarget|April 11, 2018
Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trialsGabriel von Waldenfels, Sibylle Loibl, Jenny Furlanetto, et al.
Breast Care (Basel, Switzerland)|April 19, 2024
ABC7 Consensus: Assessment by a German Group of ExpertsNina Ditsch, Michael Untch, Peter A Fasching, et al.
British Journal of Cancer|November 16, 2019
Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trialIsabell Witzel, Sibylle Loibl, Ralph Wirtz, et al.
Pageof 38

Showing results (111-120 of 377) with videos related to

Sort By:
Pageof 38
Breast Care (Basel, Switzerland)|April 7, 2016
ABC3 Consensus: Assessment by a German Group of ExpertsChristoph Thomssen, Doris Augustin, Johannes Ettl, et al.
Breast Cancer Research and Treatment|December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experienceOtto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.
Cancers|August 25, 2019
Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto TrialMalgorzata Banys-Paluchowski, Sibylle Loibl, Isabell Witzel, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
Discussion of ABC7 Consensus and German RecommendationsMichael Untch, Nina Ditsch, Peter A Fasching, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trialMarcus Schmidt, Ulrike Nitz, Toralf Reimer, et al.
Breast (Edinburgh, Scotland)|February 29, 2024
Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapyDavid Krug, Valentina Vladimirova, Michael Untch, et al.
Journal of the National Cancer Institute|March 4, 2014
ResponseVolker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Oncotarget|April 11, 2018
Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trialsGabriel von Waldenfels, Sibylle Loibl, Jenny Furlanetto, et al.
Breast Care (Basel, Switzerland)|April 19, 2024
ABC7 Consensus: Assessment by a German Group of ExpertsNina Ditsch, Michael Untch, Peter A Fasching, et al.
British Journal of Cancer|November 16, 2019
Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trialIsabell Witzel, Sibylle Loibl, Ralph Wirtz, et al.
Pageof 38